Clene GAAP EPS of -$0.85 misses by $0.27, revenue of $0.02M misses by $0.04M
Source: SeekingAlpha
2025-11-14 05:17:28 ET
More on Clene
- Seeking Alpha’s Quant Rating on Clene
- Historical earnings data for Clene
- Financial information for Clene
Read the full article on Seeking Alpha
For further details see:
Clene GAAP EPS of -$0.85 misses by $0.27, revenue of $0.02M misses by $0.04M
Clene Inc.
NASDAQ: CLNN
CLNN Trading
4.38% G/L:
$5.96 Last:
73,875 Volume:
$6 Open:
CLNN Latest News
March 12, 2026 08:00:00 am
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
February 24, 2026 08:00:00 am
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts
January 12, 2026 08:30:00 am
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
CLNN Stock Data
$47,848,385
7,019,933
8.51%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
Salt Lake City
